ARMATA PHARMACEUTICALS INC's ticker is ARMP and the CUSIP is 04216R102. A total of 20 filers reported holding ARMATA PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $300,000 | +163.2% | 100,000 | 0.0% | 0.00% | – |
Q2 2023 | $114,000 | -31.7% | 100,000 | 0.0% | 0.00% | -100.0% |
Q1 2023 | $167,000 | +34.7% | 100,000 | 0.0% | 0.00% | – |
Q4 2022 | $124,000 | -70.6% | 100,000 | 0.0% | 0.00% | -100.0% |
Q3 2022 | $422,000 | +8.5% | 100,000 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $389,000 | -20.4% | 100,000 | 0.0% | 0.00% | 0.0% |
Q1 2022 | $489,000 | -10.8% | 100,000 | 0.0% | 0.00% | 0.0% |
Q4 2021 | $548,000 | +202.8% | 100,000 | +100.0% | 0.00% | – |
Q3 2021 | $181,000 | -8.6% | 50,000 | 0.0% | 0.00% | – |
Q2 2021 | $198,000 | -17.2% | 50,000 | 0.0% | 0.00% | – |
Q1 2021 | $239,000 | +100.8% | 50,000 | +25.0% | 0.00% | – |
Q4 2020 | $119,000 | -7.0% | 40,000 | 0.0% | 0.00% | – |
Q3 2020 | $128,000 | -18.5% | 40,000 | 0.0% | 0.00% | – |
Q2 2020 | $157,000 | +26.6% | 40,000 | 0.0% | 0.00% | – |
Q1 2020 | $124,000 | +90.8% | 40,000 | +100.0% | 0.00% | – |
Q4 2019 | $65,000 | – | 20,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 113,682 | $442,000 | 0.01% |
SeaCrest Wealth Management, LLC | 17,550 | $68,000 | 0.01% |
SYNOVUS FINANCIAL CORP | 47,903 | $187,000 | 0.00% |
Edgewood Management | 100,000 | $389,000 | 0.00% |
ROYAL BANK OF CANADA | 43 | $0 | 0.00% |
VANGUARD GROUP INC | 273,150 | $1,062,000 | 0.00% |
UBS Group AG | 3,131 | $12,000 | 0.00% |
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | 571 | $2,000 | 0.00% |
DIMENSIONAL FUND ADVISORS LP | 13,072 | $51,000 | 0.00% |
BANK OF AMERICA CORP /DE/ | 634,530 | $2,468,000 | 0.00% |